2022 Q1 Form 10-Q Financial Statement

#000156459022017928 Filed on May 05, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $246.4M $218.4M
YoY Change 12.81% -0.32%
Cost Of Revenue $206.0M $187.6M
YoY Change 9.83% -2.83%
Gross Profit $40.35M $30.87M
YoY Change 30.74% 18.48%
Gross Profit Margin 16.38% 14.13%
Selling, General & Admin $40.17M $37.10M
YoY Change 8.26% 15.52%
% of Gross Profit 99.53% 120.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.508M $1.300M
YoY Change 16.0% 30.0%
% of Gross Profit 3.74% 4.21%
Operating Expenses $41.67M $38.40M
YoY Change 8.52% 19.57%
Operating Profit -$1.320M -$7.535M
YoY Change -82.48% 24.26%
Interest Expense $1.604M $1.500M
YoY Change 6.93% -44.44%
% of Operating Profit
Other Income/Expense, Net $32.00K $0.00
YoY Change -100.0%
Pretax Income $316.0K -$6.100M
YoY Change -105.18% 40.85%
Income Tax $28.00K -$1.500M
% Of Pretax Income 8.86%
Net Earnings $288.0K -$4.554M
YoY Change -106.32% 33.67%
Net Earnings / Revenue 0.12% -2.09%
Basic Earnings Per Share $0.04 -$0.60
Diluted Earnings Per Share $0.04 -$0.60
COMMON SHARES
Basic Shares Outstanding 7.406M 7.576M
Diluted Shares Outstanding 7.474M 7.576M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $415.5M $474.2M
YoY Change -12.37% 41.09%
Cash & Equivalents $46.07M $28.55M
Short-Term Investments $369.4M $445.6M
Other Short-Term Assets $132.7M $113.8M
YoY Change 16.58% -16.69%
Inventory
Prepaid Expenses
Receivables $256.3M $207.4M
Other Receivables $0.00 $8.200M
Total Short-Term Assets $516.4M $472.1M
YoY Change 9.38% 18.5%
LONG-TERM ASSETS
Property, Plant & Equipment $59.96M $58.90M
YoY Change 1.8% -1.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $160.4M $263.8M
YoY Change -39.21% -25.35%
Total Long-Term Assets $268.1M $370.6M
YoY Change -27.65% -19.64%
TOTAL ASSETS
Total Short-Term Assets $516.4M $472.1M
Total Long-Term Assets $268.1M $370.6M
Total Assets $784.5M $842.7M
YoY Change -6.9% -1.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.332M $5.600M
YoY Change -22.64% 30.23%
Accrued Expenses $382.4M $352.7M
YoY Change 8.42% 12.86%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $200.0K
YoY Change -100.0% 0.0%
Total Short-Term Liabilities $391.9M $369.8M
YoY Change 5.98% 7.69%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $3.500M
YoY Change -100.0% -5.41%
Other Long-Term Liabilities $206.9M $282.4M
YoY Change -26.73% -19.59%
Total Long-Term Liabilities $206.9M $285.9M
YoY Change -27.63% -19.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $391.9M $369.8M
Total Long-Term Liabilities $206.9M $285.9M
Total Liabilities $598.8M $658.2M
YoY Change -9.02% -5.74%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $185.7M $184.5M
YoY Change
Total Liabilities & Shareholders Equity $784.5M $842.7M
YoY Change -6.9% -1.97%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $288.0K -$4.554M
YoY Change -106.32% 33.67%
Depreciation, Depletion And Amortization $1.508M $1.300M
YoY Change 16.0% 30.0%
Cash From Operating Activities -$30.21M -$7.884M
YoY Change 283.17% -857.35%
INVESTING ACTIVITIES
Capital Expenditures -$6.754M -$1.800M
YoY Change 275.22% -47.06%
Acquisitions
YoY Change
Other Investing Activities $27.26M -$122.6M
YoY Change -122.23% -1245.79%
Cash From Investing Activities $20.51M -$124.3M
YoY Change -116.49% -1822.72%
FINANCING ACTIVITIES
Cash Dividend Paid $2.229M $2.278M
YoY Change -2.15% 0.71%
Common Stock Issuance & Retirement, Net $8.575M $3.436M
YoY Change 149.56% 15.03%
Debt Paid & Issued, Net $3.510M $55.00K
YoY Change 6281.82% 0.0%
Cash From Financing Activities -14.09M -5.061M
YoY Change 178.36% 5.92%
NET CHANGE
Cash From Operating Activities -30.21M -7.884M
Cash From Investing Activities 20.51M -124.3M
Cash From Financing Activities -14.09M -5.061M
Net Change In Cash -23.79M -137.3M
YoY Change -82.67% -4044.01%
FREE CASH FLOW
Cash From Operating Activities -$30.21M -$7.884M
Capital Expenditures -$6.754M -$1.800M
Free Cash Flow -$23.46M -$6.084M
YoY Change 285.52% -237.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
206022000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
187580000
CY2022Q1 us-gaap Gross Profit
GrossProfit
40353000
CY2021Q1 us-gaap Gross Profit
GrossProfit
30865000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
288000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-4554000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.60
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7406000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7576000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.60
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7474000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7576000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-5487000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-14358000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1633000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1348000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-153000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
865000
CY2022Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
85897000
CY2021Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
964000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14070000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
208530000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
411000
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
185000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1830000
CY2021Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
83926000
CY2022Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
50000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8575000
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2229000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
185712000
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3436000
CY2021Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
288000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-4554000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1508000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1297000
CY2022Q1 bbsi Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
1798000
CY2021Q1 bbsi Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
1872000
CY2022Q1 bbsi Accretion Amortization And Gain Loss On Investments
AccretionAmortizationAndGainLossOnInvestments
-336000
CY2021Q1 bbsi Accretion Amortization And Gain Loss On Investments
AccretionAmortizationAndGainLossOnInvestments
-203000
CY2022Q1 bbsi Deferred Income Tax Expense Benefit Including Other Comprehensive Income Tax Adjustments
DeferredIncomeTaxExpenseBenefitIncludingOtherComprehensiveIncomeTaxAdjustments
25000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1830000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1060000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
100589000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
88924000
CY2022Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
223000
CY2021Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-1724000
CY2022Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-16894000
CY2021Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
5273000
CY2022Q1 bbsi Increase Decrease In Safety Incentive Liability
IncreaseDecreaseInSafetyIncentiveLiability
-1038000
CY2021Q1 bbsi Increase Decrease In Safety Incentive Liability
IncreaseDecreaseInSafetyIncentiveLiability
-7573000
CY2022Q1 bbsi Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
1725000
CY2021Q1 bbsi Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
1887000
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
132000
CY2021Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
30000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30209000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7884000
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
6754000
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1781000
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
23444000
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
10796000
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
9381000
CY2022Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
2272000
CY2021Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
132788000
CY2022Q1 bbsi Proceeds From Sales And Maturities Of Restricted Investments
ProceedsFromSalesAndMaturitiesOfRestrictedInvestments
18735000
CY2021Q1 bbsi Proceeds From Sales And Maturities Of Restricted Investments
ProceedsFromSalesAndMaturitiesOfRestrictedInvestments
24286000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
20505000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-124346000
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3510000
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
55000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8575000
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3436000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
185000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
107000
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2229000
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2278000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
411000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
815000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-14088000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5061000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23792000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-137291000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
78629000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
233837000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54837000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
96546000
CY2022Q1 bbsi Revenue Recognition Peo Service Contract Minimum Term
RevenueRecognitionPeoServiceContractMinimumTerm
P1Y
CY2022Q1 bbsi Period For Cancellation Or Termination Of Peo Service Contract
PeriodForCancellationOrTerminationOfPeoServiceContract
P30D
CY2022Q1 bbsi Payment Term For Staffing Customers
PaymentTermForStaffingCustomers
P30D
CY2022Q1 bbsi Number Of Wholly Owned Insurance Companies
NumberOfWhollyOwnedInsuranceCompanies
2
CY2022Q1 bbsi Cash And Cash Equivalents Maximum Maturity Period
CashAndCashEquivalentsMaximumMaturityPeriod
P3M
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
555000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
460000
CY2022Q1 bbsi Estimate Of Liability For Unpaid Safety Incentives
EstimateOfLiabilityForUnpaidSafetyIncentives
3300000
CY2021Q4 bbsi Estimate Of Liability For Unpaid Safety Incentives
EstimateOfLiabilityForUnpaidSafetyIncentives
4300000
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
40000.00
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
200000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46074000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69405000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
8763000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9224000
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
68001000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
165149000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54837000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78629000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96546000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
233837000
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
401171000
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
8800000
CY2021Q4 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
1491000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7406000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7576000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7474000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7576000
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
95889
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Accounting estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of our condensed consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions. These affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Estimates are used for fair value measurement of investments, allowance for doubtful accounts, deferred income taxes, carrying values for goodwill and property, equipment and software, accrued workers’ compensation liabilities and safety incentive liabilities. Actual results may or may not differ from such estimates.</p>
CY2022Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
387786000
CY2022Q1 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
-18354000
CY2022Q1 us-gaap Marketable Securities
MarketableSecurities
369432000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
399680000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
9200000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
48440000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
65682000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
158815000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
17748000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
290685000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
180213000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
27445000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
312013000
CY2021Q4 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
279407000
CY2020Q4 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
357746000
CY2021Q1 bbsi Workers Compensation Expense Accrual Claims For Current Period
WorkersCompensationExpenseAccrualClaimsForCurrentPeriod
33270000
CY2022Q1 bbsi Workers Compensation Claim Payments Current Period
WorkersCompensationClaimPaymentsCurrentPeriod
225000
CY2022Q1 bbsi Workers Compensation Expense Accrual Claims
WorkersCompensationExpenseAccrualClaims
1365000
CY2021Q1 bbsi Workers Compensation Claim Payments Current Period
WorkersCompensationClaimPaymentsCurrentPeriod
1050000
CY2021Q1 bbsi Claim Payments Prior Period
ClaimPaymentsPriorPeriod
25767000
CY2022Q1 bbsi Workers Compensation Change In Claims Incurred In Excess Of Retention Limits
WorkersCompensationChangeInClaimsIncurredInExcessOfRetentionLimits
133000
CY2022Q1 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
262646000
CY2021Q1 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
362663000
CY2022Q1 bbsi Workers Compensation Incurred But Not Reported
WorkersCompensationIncurredButNotReported
138604000
CY2021Q1 bbsi Workers Compensation Incurred But Not Reported
WorkersCompensationIncurredButNotReported
212297000
CY2022Q1 bbsi Workers Compensation Percent To Liabilities Incurred But Not Reported
WorkersCompensationPercentToLiabilitiesIncurredButNotReported
0.53
CY2021Q1 bbsi Workers Compensation Percent To Liabilities Incurred But Not Reported
WorkersCompensationPercentToLiabilitiesIncurredButNotReported
0.59
CY2022Q1 bbsi Description Of Renewed Agreement
DescriptionOfRenewedAgreement
The Company entered into a new arrangement for its insured program effective July 1, 2021 whereby third-party insurers assume all risk of loss for claims incurred after June 30, 2021. The agreement continues to June 30, 2022 and includes a renewal commitment through June 30, 2023. The arrangement allows for premium adjustments depending on overall portfolio performance. If claims develop favorably, BBSI can participate in the savings up to $20.0 million for a twelve-month policy period. If claims develop adversely, additional premium may be charged up to $7.5 million for a twelve-month policy period.
CY2022Q1 bbsi Maximum Savings Amount If Claims Develop Favorably
MaximumSavingsAmountIfClaimsDevelopFavorably
20000000.0
CY2022Q1 bbsi Maximum Additional Premium Charged Amount If Claims Develop Adversely
MaximumAdditionalPremiumChargedAmountIfClaimsDevelopAdversely
7500000
CY2020Q2 bbsi Insurance Deposit As Security For Future Payment Obligations Under Workers Compensation Program
InsuranceDepositAsSecurityForFuturePaymentObligationsUnderWorkersCompensationProgram
115700000
CY2020Q2 bbsi Insurance Deposit As Security For Future Payment Obligations Under Workers Compensation Program
InsuranceDepositAsSecurityForFuturePaymentObligationsUnderWorkersCompensationProgram
115700000
CY2022Q1 bbsi Percentage Of Claims Excluded
PercentageOfClaimsExcluded
0.10
CY2022Q1 bbsi Insurance Deposit As Security For Future Payment Obligations Under Workers Compensation Program
InsuranceDepositAsSecurityForFuturePaymentObligationsUnderWorkersCompensationProgram
240400000
CY2021Q4 bbsi Insurance Deposit As Security For Future Payment Obligations Under Workers Compensation Program
InsuranceDepositAsSecurityForFuturePaymentObligationsUnderWorkersCompensationProgram
273600000
CY2022Q1 bbsi Collateral Securities Maintain To Cover Potential Workers Compensation Claims Losses
CollateralSecuritiesMaintainToCoverPotentialWorkersCompensationClaimsLosses
58400000
CY2021Q4 bbsi Collateral Securities Maintain To Cover Potential Workers Compensation Claims Losses
CollateralSecuritiesMaintainToCoverPotentialWorkersCompensationClaimsLosses
58400000
CY2022Q1 bbsi Standby Letters Of Credit And Surety Bond
StandbyLettersOfCreditAndSuretyBond
58400000
CY2022Q1 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
262600000
CY2021Q4 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
279400000
CY2022Q1 bbsi Workers Compensation Claims Incurred In Excess Of Retention Limits
WorkersCompensationClaimsIncurredInExcessOfRetentionLimits
2300000
CY2021 bbsi Workers Compensation Claims Incurred In Excess Of Retention Limits
WorkersCompensationClaimsIncurredInExcessOfRetentionLimits
2200000
CY2022Q1 us-gaap Line Of Credit Facility Commitment Fee Description
LineOfCreditFacilityCommitmentFeeDescription
The Agreement also provides for an unused commitment fee of 0.30% per year on the average daily unused amount of the revolving credit line, as well as a fee of 1.75% of the face amount of each letter of credit reserved under the line of credit
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
0
CY2017 us-gaap Income Tax Examination Interest Expense
IncomeTaxExaminationInterestExpense
1700
CY2018 bbsi Estimated Tax Due
EstimatedTaxDue
1700
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
0

Files In Submission

Name View Source Status
0001564590-22-017928-index-headers.html Edgar Link pending
0001564590-22-017928-index.html Edgar Link pending
0001564590-22-017928.txt Edgar Link pending
0001564590-22-017928-xbrl.zip Edgar Link pending
bbsi-10q_20220331.htm Edgar Link pending
bbsi-10q_20220331_htm.xml Edgar Link completed
bbsi-20220331.xsd Edgar Link pending
bbsi-20220331_cal.xml Edgar Link unprocessable
bbsi-20220331_def.xml Edgar Link unprocessable
bbsi-20220331_lab.xml Edgar Link unprocessable
bbsi-20220331_pre.xml Edgar Link unprocessable
bbsi-ex311_8.htm Edgar Link pending
bbsi-ex312_7.htm Edgar Link pending
bbsi-ex32_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending